Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 6, 2006 - Issue 3
Submit an article Journal homepage
413
Views
1
CrossRef citations to date
0
Altmetric
Editorial

Vitamin D (and its analogs) in the treatment and prevention of cancer

Hilary Glen Clinical Fellow and Honorary Specialist Registrar in Medical Oncology, Beatson Institute for Cancer Research, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK. [email protected]
&
Jim Cassidy Professor of Medical Oncology, Cancer Research UK Centre for Oncology and Applied Pharmacology, Division of Cancer Sciences and Molecular Oncology, University of Glasgow, Garscube Estate, Bearsden, Glasgow G61 1BD, UK. [email protected]
Pages 305-308 | Published online: 10 Jan 2014

References

  • Peller S, Stephenson CS. Skin irritation and cancer in the United States Navy. Am. J. Med. Sci. 194, 326–333 (1937).
  • Gorham ED, Garland CF, Garland FC et al. Vitamin D and prevention of colorectal cancer. J. Steroid Biochem. Mol. Biol. 97(1–2), 179–194 (2005).
  • Mangelsdorf DJ, Thummel C, Beato M et al. The nuclear receptor superfamily: the second decade. Cell 83(6), 835–839 (1995).
  • Beer TM, Munar M, Henner WD. A Phase I trial of pulse calcitriol in patients with refractory malignancies: pulse dosing permits substantial dose escalation. Cancer 91(12), 2431–2439 (2001).
  • Beer TM, Lemmon D, Lowe BA, Henner WD. High-dose weekly oral calcitriol in patients with a rising PSA after prostatectomy or radiation for prostate carcinoma. Cancer 97(5), 1217–1224 (2003).
  • Beer TM, Eilers KM, Garzotto M, Egorin MJ, Lowe BA, Henner WD. Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer. J. Clin. Oncol. 21(1), 123–128 (2003).
  • Smith DC, Johnson CS, Freeman CC, Muindi J, Wilson JW, Trump DL. A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy. Clin. Cancer Res. 5(6), 1339–1345 (1999).
  • Colston KW, Mackay AG, James SY, Binderup L, Chander S, Coombes RC. EB1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro. Biochem. Pharmacol. 44(12), 2273–2280 (1992).
  • Haq M, Kremer R, Goltzman D, Rabbani SA. A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo. J. Clin. Invest. 91(6), 2416–2422 (1993).
  • Mathiasen IS, Colston KW, Binderup L. EB 1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells. J. Steroid Biochem. Mol. Biol. 46(3), 365–371 (1993).
  • Hansen CM, Maenpaa PH. EB 1089, a novel vitamin D analog with strong antiproliferative and differentiation-inducing effects on target cells. Biochem. Pharmacol. 54(11), 1173–1179 (1997).
  • Dalhoff K, Dancey J, Astrup L et al. A Phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma. Br. J. Cancer 89(2), 252–257 (2003).
  • Evans TR, Colston KW, Lofts FJ et al. A Phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer. Br. J. Cancer 86(5), 680–685 (2002).
  • Beaugrand M, Sala M, Degos F et al. Treatment of advanced hepatocellular carcinoma by Seocalcitol (a vitamin D analogue): an international randomized double-blind placebo-controlled study in 747 patients. J. Hepatol. 42(Suppl. 2)(17), (Abstract) (2005).
  • Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int. J. Epidemiol. 9(3), 227–231 (1980).
  • Grant WB. An estimate of premature cancer mortality in the US due to inadequate doses of solar ultraviolet-B radiation. Cancer 94(6), 1867–1875 (2002).
  • Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 16(2), 83–95 (2005).
  • Garland CF, Garland FC, Gorham ED et al. The role of vitamin D in cancer prevention. Am. J. Public Health 96(2), 252–261 (2006).
  • Hartman TJ, Albert PS, Snyder K et al. The association of calcium and vitamin D with risk of colorectal adenomas. J. Nutr. 135(2), 252–259 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.